Bleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders

Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study in children (0-18 years) with a known genetic cause (proven PD), functional abnormalities, or thrombocytopenia without genetic cause (probable PD) or medical suspicion of PD (possible PD). We included 98 children (mean age 11.6 years, 55 females). PD was proven in 44, probable in 43, and possible in 11. Comorbidities were present in 43. Epistaxis, hematomas, menstrual, and perioperative bleeding were reported most frequently. Mean ISTH-BAT bleeding score was 6.1 (SD 4.0, range 0-17), with higher scores in post-pubertal females (mean 7.6) and lower scores in children with moderate thrombocytopenia (mean 4.8). Bleeding as a presenting symptom and older age were associated with higher bleeding scores. Treatment was indicated in 46 children. Most frequently, Light transmission aggregometry was abnormal for ADP, epinephrine, and thrombin. General laboratory parameters can hint to but not identify PD origin. Genetic testing led to novel diagnoses in 10 (23%) children with probable PD. We conclude that bleeding tendency is prominent but variable in children with PD. Routine laboratory tests are useful, but fail to diagnose the origin of PD. Therefore, genetic analysis is essential, especially as PD can be part of a syndrome leading to comorbidities or predispose for malignancies, both impacting counseling and surveillance. We propose a classification based on functional and genetic analysis leading to either an isolated or syndrome-associated inherited PD or a functional PD. Trial Registration: ABR NL55101.078.16.

Authors

Institutions

Publication Details

Journal
European Journal Of Haematology
Published
2026-11-17
DOI
https://doi.org/10.1111/ejh.70346
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders

Marieke Joosten, Caroline S. B. Veen, Leendert Porcelijn, Karin van Leeuwen et al.
European Journal Of Haematology
Platelet Disorders and Treatments
article

Bleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders

Marieke Joosten, Caroline S. B. Veen, Leendert Porcelijn, Karin van Leeuwen, Masja de Haas, Leo M. van de Watering, Elise J. Huisman, Marjon H. Cnossen, Ferdows Atiq, Marieke J.H.A. Kruip
article en

Abstract

Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study in children (0-18 years) with a known genetic cause (proven PD), functional abnormalities, or thrombocytopenia without genetic cause (probable PD) or medical suspicion of PD (possible PD). We included 98 children (mean age 11.6 years, 55 females). PD was proven in 44, probable in 43, and possible in 11. Comorbidities were present in 43. Epistaxis, hematomas, menstrual, and perioperative bleeding were reported most frequently. Mean ISTH-BAT bleeding score was 6.1 (SD 4.0, range 0-17), with higher scores in post-pubertal females (mean 7.6) and lower scores in children with moderate thrombocytopenia (mean 4.8). Bleeding as a presenting symptom and older age were associated with higher bleeding scores. Treatment was indicated in 46 children. Most frequently, Light transmission aggregometry was abnormal for ADP, epinephrine, and thrombin. General laboratory parameters can hint to but not identify PD origin. Genetic testing led to novel diagnoses in 10 (23%) children with probable PD. We conclude that bleeding tendency is prominent but variable in children with PD. Routine laboratory tests are useful, but fail to diagnose the origin of PD. Therefore, genetic analysis is essential, especially as PD can be part of a syndrome leading to comorbidities or predispose for malignancies, both impacting counseling and surveillance. We propose a classification based on functional and genetic analysis leading to either an isolated or syndrome-associated inherited PD or a functional PD. Trial Registration: ABR NL55101.078.16.

European Journal Of Haematology
Royal College of Surgeons in Ireland (IE), Leiden University Medical Center (NL), Erasmus MC (NL), Sanquin (NL), Erasmus MC - Sophia Children’s Hospital (NL), Erasmus University Rotterdam (NL)
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon